Evidence map›Paper›PMID 25412209›Full record

ArticleBiochemistry2014

Contributions of unique active site residues of eukaryotic UDP-galactopyranose mutases to substrate recognition and active site dynamics.

Isabel Da Fonseca, Insaf A Qureshi, Ritcha Mehra-Chaudhary, Karina Kizjakina, John J Tanner, Pablo Sobrado

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Isabel Da FonsecaDepartment of Biochemistry, Virginia Tech , Blacksburg, Virginia 24061, United States.
Insaf A Qureshi
Ritcha Mehra-Chaudhary
Karina Kizjakina
John J Tanner
Pablo Sobrado
Virginia Tech · USUniversity of Hyderabad · IN

Funding

Overall EvaluationP41GM103403 · NIGMS · CORNELL UNIVERSITY · PI EALICK, STEVEN E · 2012 to 2017
$14.3M
Mechanistic and structural studies of eukaryotic UDP-galactopyranose mutasesR01GM094469 · NIGMS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI SOBRADO, PABLO, TANNER, JOHN J · 2010 to 2019
$2.0M
NIGMS NIH HHS P41 GM103403NIGMS NIH HHS R01 GM094469NIGMS NIH HHS R01GM094469
6 · The paper itself

Abstract

UDP-galactopyranose mutase (UGM) catalyzes the interconversion between UDP-galactopyranose and UDP-galactofuranose. Absent in humans, galactofuranose is found in bacterial and fungal cell walls and is a cell surface virulence factor in protozoan parasites. For these reasons, UGMs are targets for drug discovery. Here, we report a mutagenesis and structural study of the UGMs from Aspergillus fumigatus and Trypanosoma cruzi focused on active site residues that are conserved in eukaryotic UGMs but are absent or different in bacterial UGMs. Kinetic analysis of the variants F66A, Y104A, Q107A, N207A, and Y317A (A. fumigatus numbering) show decreases in k(cat)/K(M) values of 200-1000-fold for the mutase reaction. In contrast, none of the mutations significantly affect the kinetics of enzyme activation by NADPH. These results indicate that the targeted residues are important for promoting the transition state conformation for UDP-galactofuranose formation. Crystal structures of the A. fumigatus mutant enzymes were determined in the presence and absence of UDP to understand the structural consequences of the mutations. The structures suggest important roles for Asn207 in stabilizing the closed active site, and Tyr317 in positioning of the uridine ring. Phe66 and the corresponding residue in Mycobacterium tuberculosis UGM (His68) play a role as the backstop, stabilizing the galactopyranose group for nucleophilic attack. Together, these results provide insight into the essentiality of the targeted residues for realizing maximal catalytic activity and a proposal for how conformational changes that close the active site are temporally related and coupled together.

Indexed as

BiocatalysisModels, MolecularAmino Acid SubstitutionAspergillus fumigatusCatalytic DomainFungal ProteinsGalactoseIntramolecular TransferasesKineticsLigandsMutagenesis, Site-DirectedMutant ProteinsNADPProtein ConformationProtein StabilityProtozoan ProteinsFungal ProteinsGalactoseIntramolecular TransferasesLigandsMutant ProteinsNADPProtozoan ProteinsUDP-galactopyranose mutaseUridine Diphosphateuridine diphosphate galactofuranoseUridine Diphosphate Galactose

Identifiers

PMID25412209
PMCPMC4270374
OpenAlexW2327564311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.